Armaan Kush Malhotra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Armaan Kush Malhotra has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
- Jefferson R. Wilson
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Canada
9 shared publications Husain Shakil
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario
6 shared publications- Vishwathsen Karthikeyan
University of Toronto
6 shared publications - Christopher D. Witiw
University of Toronto
5 shared publications - Husain Shakil
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
5 shared publications - Christopher S. Lozano
University of Toronto
4 shared publications
Latest Publications
- 30 September 2026
- Published by Wolters Kluwer Health in Spine
Mental Health Recovery Trajectories After Surgery for Degenerative Cervical Myelopathy
Study Design.: Retrospective analysis of a multicenter, prospective observational cohort. Objective.: To identify distinct postoperative trajectories of mental health following surgery for degenerative cervical myelopathy (DCM) and to assess the independent association between trajectory membership and 12-month patient satisfaction. Summary of Background Data.: Although surgery improves neurological and functional outcomes for patients with DCM, its impact on mental health remains poorly characterized. Patients with DCM frequently report poor mental well-being, which may influence quality of life and satisfaction with treatment. Methods.: We analyzed data from the ongoing Canadian Spine Outcomes Research Network (CSORN) multicenter prospective observational DCM study. Group-based trajectory modeling (GBTM) was used to identify latent MCS recovery trajectories. Logistic regression evaluated associations between trajectory group membership and 12-month satisfaction, adjusting for demographic and clinical variables. Results.: Among the 729 patients included, four distinct trajectories of mental health HRQoL recovery were identified based on longitudinal MCS scores: Low-stable (persistently low MCS [12%]), Moderate-stable (intermediate and unchanged MCS [36%]), Good-stable (high and stable MCS [38%]), and Improved (low baseline MCS with postoperative improvement [14%]). Pairwise comparisons showed that the Improved group achieved significantly greater gains in disability (NDI, P P =0.002), mental health HRQoL (MCS, P P =0.001) compared with the Low-stable group, while changes in neurologic function and arm pain did not differ. Trajectory group membership was associated with satisfaction: compared with Low-stable, Good-stable (OR 7.39, 95% CI 3.09–17.70) and Improved (OR 4.18, 95% CI 1.77–9.87) groups were significantly more likely to report being satisfied at 12 months. Conclusion.: Mental health HRQoL recovery following DCM surgery is heterogeneous, with only a minority of patients achieving substantial postoperative improvement. Whether routine assessment of mental-health HRQoL or targeted perioperative support alters outcomes is an area of research that warrants prospective study.
- 30 September 2026
- Published by Wolters Kluwer Health in Spine
Mental Health Recovery Trajectories After Surgery for Degenerative Cervical Myelopathy
Study Design.: Retrospective analysis of a multicenter, prospective observational cohort. Objective.: To identify distinct postoperative trajectories of mental health following surgery for degenerative cervical myelopathy (DCM) and to assess the independent association between trajectory membership and 12-month patient satisfaction. Summary of Background Data.: Although surgery improves neurological and functional outcomes for patients with DCM, its impact on mental health remains poorly characterized. Patients with DCM frequently report poor mental well-being, which may influence quality of life and satisfaction with treatment. Methods.: We analyzed data from the ongoing Canadian Spine Outcomes Research Network (CSORN) multicenter prospective observational DCM study. Group-based trajectory modeling (GBTM) was used to identify latent MCS recovery trajectories. Logistic regression evaluated associations between trajectory group membership and 12-month satisfaction, adjusting for demographic and clinical variables. Results.: Among the 729 patients included, four distinct trajectories of mental health HRQoL recovery were identified based on longitudinal MCS scores: Low-stable (persistently low MCS [12%]), Moderate-stable (intermediate and unchanged MCS [36%]), Good-stable (high and stable MCS [38%]), and Improved (low baseline MCS with postoperative improvement [14%]). Pairwise comparisons showed that the Improved group achieved significantly greater gains in disability (NDI, P P =0.002), mental health HRQoL (MCS, P P =0.001) compared with the Low-stable group, while changes in neurologic function and arm pain did not differ. Trajectory group membership was associated with satisfaction: compared with Low-stable, Good-stable (OR 7.39, 95% CI 3.09–17.70) and Improved (OR 4.18, 95% CI 1.77–9.87) groups were significantly more likely to report being satisfied at 12 months. Conclusion.: Mental health HRQoL recovery following DCM surgery is heterogeneous, with only a minority of patients achieving substantial postoperative improvement. Whether routine assessment of mental-health HRQoL or targeted perioperative support alters outcomes is an area of research that warrants prospective study.
- 22 September 2026
- Published by Wolters Kluwer Health in Neurosurgery
Days at Home After Traumatic Spinal Cord Injury: An Interpretable Patient-Centered Outcome From Administrative Health Data
BACKGROUND AND OBJECTIVES: Days alive and at home (DAH) is a patient-centered outcome that integrates survival, institutional care utilization, and community dwelling. Although DAH has been validated in other clinical contexts, its validity after traumatic spinal cord injury (SCI) remains unknown. We evaluated DAH at 180 days after injury (DAH 180 ) as a clinically meaningful outcome for traumatic SCI using administrative health data. METHODS: We conducted a population-based, multicenter retrospective cohort study using linked administrative health data from Ontario, Canada. Adults with acute traumatic SCI admitted to trauma centers between 2009 and 2023 were included. The primary outcome was DAH 180 ; secondary outcomes included DAH at 1 and 2 years. Construct validity was assessed using multivariable quantile regression and associations with rehabilitation discharge motor Functional Independence Measure scores. Predictive validity was evaluated using correlations between DAH 180 and subsequent DAH accrual and 1-year healthcare expenditures. Minimum important differences were estimated using distribution- and anchor-based methods. RESULTS: The cohort included 693 patients. Median DAH 180 was 63 days (IQR 0-118 days), with many patients accruing zero days at home, particularly after cervical complete injuries. Lower median DAH 180 was associated with older age, higher injury severity, complete injury, and frailty. DAH 180 correlated moderately with motor Functional Independence Measure scores at rehabilitation discharge (ρ = 0.69; 95% CI, 0.63-0.74) and remained independently associated after multivariable adjustment. Among 180-day survivors, DAH 180 correlated with subsequent DAH from 180 days to 1 year (ρ = 0.61, 95% CI, 0.55-0.67) and from 1 to 2 years (ρ = 0.47, 95% CI, 0.39-0.53), and was inversely associated with 1-year healthcare expenditures (ρ = −0.41, 95% CI, −0.46 to −0.33). The average estimated minimum important differences was 23 days. CONCLUSION: DAH 180 demonstrated construct, predictive, and face validity after traumatic SCI and may provide a feasible, patient-centered outcome for linked population-based administrative data research.
- 22 September 2026
- Published by Wolters Kluwer Health in Neurosurgery
Days at Home After Traumatic Spinal Cord Injury: An Interpretable Patient-Centered Outcome From Administrative Health Data
BACKGROUND AND OBJECTIVES: Days alive and at home (DAH) is a patient-centered outcome that integrates survival, institutional care utilization, and community dwelling. Although DAH has been validated in other clinical contexts, its validity after traumatic spinal cord injury (SCI) remains unknown. We evaluated DAH at 180 days after injury (DAH 180 ) as a clinically meaningful outcome for traumatic SCI using administrative health data. METHODS: We conducted a population-based, multicenter retrospective cohort study using linked administrative health data from Ontario, Canada. Adults with acute traumatic SCI admitted to trauma centers between 2009 and 2023 were included. The primary outcome was DAH 180 ; secondary outcomes included DAH at 1 and 2 years. Construct validity was assessed using multivariable quantile regression and associations with rehabilitation discharge motor Functional Independence Measure scores. Predictive validity was evaluated using correlations between DAH 180 and subsequent DAH accrual and 1-year healthcare expenditures. Minimum important differences were estimated using distribution- and anchor-based methods. RESULTS: The cohort included 693 patients. Median DAH 180 was 63 days (IQR 0-118 days), with many patients accruing zero days at home, particularly after cervical complete injuries. Lower median DAH 180 was associated with older age, higher injury severity, complete injury, and frailty. DAH 180 correlated moderately with motor Functional Independence Measure scores at rehabilitation discharge (ρ = 0.69; 95% CI, 0.63-0.74) and remained independently associated after multivariable adjustment. Among 180-day survivors, DAH 180 correlated with subsequent DAH from 180 days to 1 year (ρ = 0.61, 95% CI, 0.55-0.67) and from 1 to 2 years (ρ = 0.47, 95% CI, 0.39-0.53), and was inversely associated with 1-year healthcare expenditures (ρ = −0.41, 95% CI, −0.46 to −0.33). The average estimated minimum important differences was 23 days. CONCLUSION: DAH 180 demonstrated construct, predictive, and face validity after traumatic SCI and may provide a feasible, patient-centered outcome for linked population-based administrative data research.
- Open Access
- 9 June 2026
- Published by Elsevier in The Spine Journal
- Vol. 26 (11) , 2248-2259
The value of recovery after spinal cord injury: long-term healthcare costs in relation to home time in a population-based cohort
- 9 June 2026
- Published by Elsevier in The Spine Journal
- Vol. 26 (11) , 2248-2259
Open AccessThe value of recovery after spinal cord injury: long-term healthcare costs in relation to home time in a population-based cohort
- 28 April 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (8) , e210184
Author Response: Days at Home After Traumatic Brain Injury: Moving Beyond Mortality to Evaluate Patient-Centered Outcomes Using Population Health Data
- 28 April 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (8) , e210184
Author Response: Days at Home After Traumatic Brain Injury: Moving Beyond Mortality to Evaluate Patient-Centered Outcomes Using Population Health Data
- 24 February 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (4) , e214571
Predicting Return Home After Moderate-to-Severe Traumatic Brain Injury
Days alive and at home (DAH) is a validated outcome measure that captures health care transitions between time spent at home vs various nonhome care settings, offering a more nuanced patient-centered understanding of recovery. We aimed to (1) characterize long-term recovery trajectories for adults with moderate-to-severe traumatic brain injury (msTBI) using DAH and (2) develop and internally validate a clinical prediction model for favorable vs unfavorable recovery. This multicenter retrospective population-based cohort study was performed in Ontario, Canada; we identified adults hospitalized with isolated msTBI between 2009 and 2021 that survived beyond 72 hours postadmission. DAH was calculated in 30-day intervals from index admission through 3 years postinjury. Latent class mixed modeling identified unique recovery trajectories. Sociodemographic, clinical, and injury variables were then evaluated as candidate predictors. Logistic regression, penalized regression, and machine learning approaches were compared for discrimination of favorable (early, intermediate, or late recovery) vs unfavorable (delayed deterioration or poor recovery) trajectories. Model performance was evaluated in a held-out test set using area under the receiver operating characteristic curve (AUC) with 95% CIs. There were 3,004 adults included in the cohort with an overall male predominance (n = 2,284, 76.1%), and the average age was 49.6 years (SD 21.4). Latent class mixed modeling revealed 5 distinct DAH trajectories: early recovery (38.6%), intermediate recovery (27.5%), and late recovery (3.2%) groups were characterized by return to the community at varying time intervals; by contrast, delayed deterioration (3.4%) and poor recovery (27.3%) groups experienced limited time at home at final follow-up. Patients in the unfavorable recovery trajectory groups were older, frailer, and more likely to sustain fall-related injuries. Radiographic predictors of poor outcome included subdural hematoma, large intraparenchymal hematoma, diffuse axonal injury, and cerebral edema. Using various demographic, injury and radiographic characteristics, a prediction model (DAH-TBI calculator) could discriminate trajectories with an AUC of 0.812 (95% CI 782-0.842) on a held-out internal validation data set. Our findings emphasize a longer period of postinjury outcome observation may be necessary to capture societal reintegration after msTBI. We developed and internally validated the DAH-TBI calculator to predict long-term postinjury outcomes.
- 24 February 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (4) , e214571
Predicting Return Home After Moderate-to-Severe Traumatic Brain Injury
Days alive and at home (DAH) is a validated outcome measure that captures health care transitions between time spent at home vs various nonhome care settings, offering a more nuanced patient-centered understanding of recovery. We aimed to (1) characterize long-term recovery trajectories for adults with moderate-to-severe traumatic brain injury (msTBI) using DAH and (2) develop and internally validate a clinical prediction model for favorable vs unfavorable recovery. This multicenter retrospective population-based cohort study was performed in Ontario, Canada; we identified adults hospitalized with isolated msTBI between 2009 and 2021 that survived beyond 72 hours postadmission. DAH was calculated in 30-day intervals from index admission through 3 years postinjury. Latent class mixed modeling identified unique recovery trajectories. Sociodemographic, clinical, and injury variables were then evaluated as candidate predictors. Logistic regression, penalized regression, and machine learning approaches were compared for discrimination of favorable (early, intermediate, or late recovery) vs unfavorable (delayed deterioration or poor recovery) trajectories. Model performance was evaluated in a held-out test set using area under the receiver operating characteristic curve (AUC) with 95% CIs. There were 3,004 adults included in the cohort with an overall male predominance (n = 2,284, 76.1%), and the average age was 49.6 years (SD 21.4). Latent class mixed modeling revealed 5 distinct DAH trajectories: early recovery (38.6%), intermediate recovery (27.5%), and late recovery (3.2%) groups were characterized by return to the community at varying time intervals; by contrast, delayed deterioration (3.4%) and poor recovery (27.3%) groups experienced limited time at home at final follow-up. Patients in the unfavorable recovery trajectory groups were older, frailer, and more likely to sustain fall-related injuries. Radiographic predictors of poor outcome included subdural hematoma, large intraparenchymal hematoma, diffuse axonal injury, and cerebral edema. Using various demographic, injury and radiographic characteristics, a prediction model (DAH-TBI calculator) could discriminate trajectories with an AUC of 0.812 (95% CI 782-0.842) on a held-out internal validation data set. Our findings emphasize a longer period of postinjury outcome observation may be necessary to capture societal reintegration after msTBI. We developed and internally validated the DAH-TBI calculator to predict long-term postinjury outcomes.
- Open Access
- 5 January 2026
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (1_suppl) , 43S-52S
Laminoplasty Versus Laminectomy and Fusion in the Treatment of Degenerative Cervical Myelopathy: A Systematic Review and Meta-Analysis of Cost and Patient-Centered Outcomes in the United States
Study design: Systematic review and meta-analysis. Objective: This systematic review and meta-analysis compared cervical laminoplasty (LP) with laminectomy and fusion (LF) for the treatment of degenerative cervical myelopathy (DCM), focusing on healthcare costs and patient-centered outcomes. Methods: A systematic review of EMBASE and Medline (inception to September 2024) identified studies comparing LP and LF for multilevel DCM. Outcomes included return-to-work (RTW), direct treatment costs, and changes in pain and opioid use. Meta-analyses were performed using random-effects models to estimate pooled mean differences (MD) between treatment arms and mean per treatment for study outcomes. Study quality was assessed with the Newcastle-Ottawa Scale. Results: Twelve retrospective cohort studies (7581 patients; LP: 1,848, LF: 5733) met inclusion criteria. After appraising the included studies, we determined that 25% were of high quality, 67% were of moderate quality, and 8% were of low quality. LF had higher treatment costs ($74,772.8 USD, 95% CI $29,503.72-$120,041.88) than LP ($52,109.07 USD, 95% CI $12,234.14-$91,985.43), with an MD of −$21,620.69 USD (95% CI −$35,215 to −$8025.53, I 2 = 95%). LF led to greater pain reduction (MD in VAS = 1.60, 95% CI 0.36-2.84, I 2 = 63%). Opioid use was inconsistently reported, preventing meta-analysis. One study found higher RTW rates at 12 months for LP (88.9%) vs LF (64.3%). Conclusion: LF incurred greater costs but provided superior pain relief. Significant heterogeneity and limited high-quality evidence highlight the need for further research on cost-effectiveness and patient-centered outcomes.
- 5 January 2026
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (1_suppl) , 43S-52S
Open AccessLaminoplasty Versus Laminectomy and Fusion in the Treatment of Degenerative Cervical Myelopathy: A Systematic Review and Meta-Analysis of Cost and Patient-Centered Outcomes in the United States
Study design: Systematic review and meta-analysis. Objective: This systematic review and meta-analysis compared cervical laminoplasty (LP) with laminectomy and fusion (LF) for the treatment of degenerative cervical myelopathy (DCM), focusing on healthcare costs and patient-centered outcomes. Methods: A systematic review of EMBASE and Medline (inception to September 2024) identified studies comparing LP and LF for multilevel DCM. Outcomes included return-to-work (RTW), direct treatment costs, and changes in pain and opioid use. Meta-analyses were performed using random-effects models to estimate pooled mean differences (MD) between treatment arms and mean per treatment for study outcomes. Study quality was assessed with the Newcastle-Ottawa Scale. Results: Twelve retrospective cohort studies (7581 patients; LP: 1,848, LF: 5733) met inclusion criteria. After appraising the included studies, we determined that 25% were of high quality, 67% were of moderate quality, and 8% were of low quality. LF had higher treatment costs ($74,772.8 USD, 95% CI $29,503.72-$120,041.88) than LP ($52,109.07 USD, 95% CI $12,234.14-$91,985.43), with an MD of −$21,620.69 USD (95% CI −$35,215 to −$8025.53, I 2 = 95%). LF led to greater pain reduction (MD in VAS = 1.60, 95% CI 0.36-2.84, I 2 = 63%). Opioid use was inconsistently reported, preventing meta-analysis. One study found higher RTW rates at 12 months for LP (88.9%) vs LF (64.3%). Conclusion: LF incurred greater costs but provided superior pain relief. Significant heterogeneity and limited high-quality evidence highlight the need for further research on cost-effectiveness and patient-centered outcomes.
- Open Access
- 5 January 2026
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (1_suppl) , 28S-42S
Cervical Laminectomy for Degenerative Cervical Myelopathy: Is There A Role in the Modern Day? A Systematic Review and Meta-Analysis
Study Design: Systematic Review and Meta-Analysis. Objectives: To compare clinical outcomes in degenerative cervical myelopathy (DCM) patients treated with laminectomy alone (LA) vs laminectomy with fusion (LF) and determine post-laminectomy kyphosis incidence. Methods: We searched PubMed, Scopus, Embase, Web of Science, and MEDLINE from inception-September 2024 for studies comparing LA and LF for DCM. Outcomes assessed included post-laminectomy kyphosis, neurological recovery outcomes, patient-reported outcomes (PROs), and complication rates. Meta-analyses were performed using random-effects models. Results: Twenty-seven studies including 3286 patients (2272 LA and 1014 LF), met the inclusion criteria. The pooled incidence of post-laminectomy kyphosis in the LA patients was 2.02 events per 100 person-years (95% CI: 1.26-2.78). Post-laminectomy kyphosis declined from 3.67 cases per 100 person-years in pre-2004 studies, to 0.88 cases per 100 person-years in post-2014 studies. No significant differences were observed between LA and LF in neurologic recovery (SMD 0.29, 95% CI 0.02-0.59), pain score improvement (SMD 0.13, 95% CI: −0.38 to 0.64) and complications (OR 0.77, 95 % CI 0.29-2.08), although subgroup analysis demonstrated that the risk of complications in LA may be lower in patients with less than four operative levels. Conclusions: Although the annual rate of kyphosis after LA is approximately 2 events per 100 person-years, PROs and complication rates may be similar between LA and LF. These findings should be interpreted with the caveat of considerable heterogeneity between studies and further randomized trials are needed to better delineate the benefits of each approach and to optimize patient selection.
- 5 January 2026
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (1_suppl) , 28S-42S
Open AccessCervical Laminectomy for Degenerative Cervical Myelopathy: Is There A Role in the Modern Day? A Systematic Review and Meta-Analysis
Study Design: Systematic Review and Meta-Analysis. Objectives: To compare clinical outcomes in degenerative cervical myelopathy (DCM) patients treated with laminectomy alone (LA) vs laminectomy with fusion (LF) and determine post-laminectomy kyphosis incidence. Methods: We searched PubMed, Scopus, Embase, Web of Science, and MEDLINE from inception-September 2024 for studies comparing LA and LF for DCM. Outcomes assessed included post-laminectomy kyphosis, neurological recovery outcomes, patient-reported outcomes (PROs), and complication rates. Meta-analyses were performed using random-effects models. Results: Twenty-seven studies including 3286 patients (2272 LA and 1014 LF), met the inclusion criteria. The pooled incidence of post-laminectomy kyphosis in the LA patients was 2.02 events per 100 person-years (95% CI: 1.26-2.78). Post-laminectomy kyphosis declined from 3.67 cases per 100 person-years in pre-2004 studies, to 0.88 cases per 100 person-years in post-2014 studies. No significant differences were observed between LA and LF in neurologic recovery (SMD 0.29, 95% CI 0.02-0.59), pain score improvement (SMD 0.13, 95% CI: −0.38 to 0.64) and complications (OR 0.77, 95 % CI 0.29-2.08), although subgroup analysis demonstrated that the risk of complications in LA may be lower in patients with less than four operative levels. Conclusions: Although the annual rate of kyphosis after LA is approximately 2 events per 100 person-years, PROs and complication rates may be similar between LA and LF. These findings should be interpreted with the caveat of considerable heterogeneity between studies and further randomized trials are needed to better delineate the benefits of each approach and to optimize patient selection.
- 2 December 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 108 (1) , 51-59
Trends and Impact of Pharmacological VTE Prophylaxis Timing for Traumatic Cervical Spinal Cord Injury Across North American Trauma Centers
Background: The aims of this study were to evaluate the timing and trend of venous thromboembolism (VTE) prophylaxis initiation following surgical intervention, and the impact of VTE prophylaxis timing on the occurrence of VTE complications, across North American trauma centers in patients with complete traumatic cervical spinal cord injury (SCI). Methods: This retrospective, observational cohort study utilized data from the American College of Surgeons (ACS) Trauma Quality Improvement Program (TQIP) from 2013 to 2020. We identified surgically treated patients with complete traumatic cervical SCI. Patient variables included age, sex, race, insurance coverage, and comorbidity status. Outcomes of interest included time to VTE prophylaxis following surgery and the occurrence of VTE complications. Mixed-effect regression models were constructed to evaluate the adjusted estimate for each outcome accounting for patient-, injury-, and hospital-level covariates. Results: The study included 5,325 patients treated across 463 trauma centers. The mean age in the cohort was 46.7 ± 18.9 years, with male predominance (81.1%). Race was predominantly White (62.3%) and Black (23.0%). The mean time to VTE prophylaxis initiation was 90 ± 112 hours, and the median time was 65 hours (interquartile range, 39 to 105 hours). The annual trend of VTE prophylaxis initiation after surgery was a decrease by 5.2 hours per year over the 8-year study interval. This was associated with an annual reduction of 6.2% in the odds of VTE complication occurrence. Multivariable mixed-effect regression models demonstrated a significant reduction in time to VTE prophylaxis (mean difference, −3.7 hours per year [95% confidence interval [CI], −5.3 to −2.1 hours per year]; p < 0.001) and VTE complications (odds ratio, 0.93 per year [95% CI, 0.88 to 0.98 per year]; p = 0.01) over the study period, after adjustment. Conclusions: This analysis provides insight into VTE prophylaxis practice patterns following surgery for complete cervical SCI across North American trauma centers from 2013 to 2020. The timing of VTE prophylaxis initiation consistently decreased, which appeared to be associated with a significant reduction found in VTE complications. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
- 2 December 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 108 (1) , 51-59
Trends and Impact of Pharmacological VTE Prophylaxis Timing for Traumatic Cervical Spinal Cord Injury Across North American Trauma Centers
Background: The aims of this study were to evaluate the timing and trend of venous thromboembolism (VTE) prophylaxis initiation following surgical intervention, and the impact of VTE prophylaxis timing on the occurrence of VTE complications, across North American trauma centers in patients with complete traumatic cervical spinal cord injury (SCI). Methods: This retrospective, observational cohort study utilized data from the American College of Surgeons (ACS) Trauma Quality Improvement Program (TQIP) from 2013 to 2020. We identified surgically treated patients with complete traumatic cervical SCI. Patient variables included age, sex, race, insurance coverage, and comorbidity status. Outcomes of interest included time to VTE prophylaxis following surgery and the occurrence of VTE complications. Mixed-effect regression models were constructed to evaluate the adjusted estimate for each outcome accounting for patient-, injury-, and hospital-level covariates. Results: The study included 5,325 patients treated across 463 trauma centers. The mean age in the cohort was 46.7 ± 18.9 years, with male predominance (81.1%). Race was predominantly White (62.3%) and Black (23.0%). The mean time to VTE prophylaxis initiation was 90 ± 112 hours, and the median time was 65 hours (interquartile range, 39 to 105 hours). The annual trend of VTE prophylaxis initiation after surgery was a decrease by 5.2 hours per year over the 8-year study interval. This was associated with an annual reduction of 6.2% in the odds of VTE complication occurrence. Multivariable mixed-effect regression models demonstrated a significant reduction in time to VTE prophylaxis (mean difference, −3.7 hours per year [95% confidence interval [CI], −5.3 to −2.1 hours per year]; p < 0.001) and VTE complications (odds ratio, 0.93 per year [95% CI, 0.88 to 0.98 per year]; p = 0.01) over the study period, after adjustment. Conclusions: This analysis provides insight into VTE prophylaxis practice patterns following surgery for complete cervical SCI across North American trauma centers from 2013 to 2020. The timing of VTE prophylaxis initiation consistently decreased, which appeared to be associated with a significant reduction found in VTE complications. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
- Open Access
Bridging the representation gap in the surgical workforce: a scoping review protocol of programmes and interventions to support surgical careers for underrepresented minority learners
Introduction Despite increasing proportions of underrepresented minority (URM) medical school graduates, their progression into surgical training and leadership remains disproportionately low. Barriers such as financial constraints, limited mentorship and implicit bias contribute to this disparity, creating a disconnect between the diversity of patient populations and those providing care. While interventions such as mentorship programmes and pipeline initiatives have been implemented, their overall effectiveness has not been systematically evaluated. The primary aim of this scoping review is to map the current landscape of interventions, programmes and policies designed to enhance access to surgical careers for URM learners. Methods and analysis Searches will be conducted on EMBASE, Web of Science and OVID MEDLINE. Three independent reviewers will screen references, extract data and perform analyses with disagreements adjudicated by a fourth reviewer. This review will include studies conducted across all levels of training: secondary (high school or secondary school), postsecondary (undergraduate, medical school) and postgraduate (residency, fellowship), with no geographical restrictions. The definition of URM will be accepted as reported within each individual study, allowing for variability in racial, ethnic, gender, socioeconomic or other criteria. The review will include any structured interventions, programmes or policies aimed at increasing URM representation in surgical education. Data on the nature, duration and target population of each intervention will be extracted. The primary outcome will be the reported impact of interventions on URM representation or participation in surgical education. Secondary outcomes will include characteristics of the study participants, definitions of URM status and any qualitative or quantitative evaluations of intervention effectiveness. Ethics and dissemination Research ethics approval is not required under University of Toronto policy. Study results will be reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines. Results will be disseminated to relevant stakeholders at conference presentation(s) and submitted for publication in a peer-reviewed journal.
Open AccessBridging the representation gap in the surgical workforce: a scoping review protocol of programmes and interventions to support surgical careers for underrepresented minority learners
Introduction Despite increasing proportions of underrepresented minority (URM) medical school graduates, their progression into surgical training and leadership remains disproportionately low. Barriers such as financial constraints, limited mentorship and implicit bias contribute to this disparity, creating a disconnect between the diversity of patient populations and those providing care. While interventions such as mentorship programmes and pipeline initiatives have been implemented, their overall effectiveness has not been systematically evaluated. The primary aim of this scoping review is to map the current landscape of interventions, programmes and policies designed to enhance access to surgical careers for URM learners. Methods and analysis Searches will be conducted on EMBASE, Web of Science and OVID MEDLINE. Three independent reviewers will screen references, extract data and perform analyses with disagreements adjudicated by a fourth reviewer. This review will include studies conducted across all levels of training: secondary (high school or secondary school), postsecondary (undergraduate, medical school) and postgraduate (residency, fellowship), with no geographical restrictions. The definition of URM will be accepted as reported within each individual study, allowing for variability in racial, ethnic, gender, socioeconomic or other criteria. The review will include any structured interventions, programmes or policies aimed at increasing URM representation in surgical education. Data on the nature, duration and target population of each intervention will be extracted. The primary outcome will be the reported impact of interventions on URM representation or participation in surgical education. Secondary outcomes will include characteristics of the study participants, definitions of URM status and any qualitative or quantitative evaluations of intervention effectiveness. Ethics and dissemination Research ethics approval is not required under University of Toronto policy. Study results will be reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines. Results will be disseminated to relevant stakeholders at conference presentation(s) and submitted for publication in a peer-reviewed journal.
- 28 August 2025
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 2 (9)
Energy Considerations for Scaling Artificial Intelligence Adoption in Medicine: First Do No Harm
- 28 August 2025
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 2 (9)
Energy Considerations for Scaling Artificial Intelligence Adoption in Medicine: First Do No Harm